Boothbay Fund Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
|
|||||
|
2025
Q4 | $204K | Sell |
|
|||||
|
2025
Q3 | $402K | Sell |
|
|||||
|
2025
Q2 | $881K | Sell |
|
|||||
|
2025
Q1 | $1.33M | Sell |
|
|||||
|
2024
Q4 | $1.6M | Sell |
|
|||||
|
2024
Q3 | $2.11M | Sell |
|
|||||
|
2024
Q2 | $1.87M | Hold |
|
|||||
|
2024
Q1 | $1.93M | Buy |
|
|||||
|
2023
Q4 | $1.82M | Hold |
|
|||||
|
2023
Q3 | $1.27M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $379K | Buy |
|
|||||
|
2018
Q2 | $263K | Sell |
|
|||||
|
2018
Q1 | $294K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $190K | Sell |
|
|||||
|
2017
Q1 | $265K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $97K | Sell |
|
|||||
|
2015
Q3 | $191K | Buy |
|